The evaluation for effectiveness of ceramide cream for skin diseases with barrier dysfunction

The evaluation for effectiveness of ceramide cream for skin diseases with barrier dysfunction - The evaluation for effectiveness of ceramide cream for skin diseases with barrier dysfunction

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019217

Enrollment

Registered

2016-01-01

Start date

2013-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin diseases with barrier dysfunction

Interventions

Topical application of ceramide cream twice a day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with psoriasis

Exclusion criteria

Exclusion criteria: Patients with the other inflammatory skin diseases

Design outcomes

Primary

Measure	Time frame
Effectiveness of ceramide cream for skin diseases with barrier dysfunction is assessed with skin color and induration in erythema every week.	—

Secondary

Measure	Time frame
Safety of ceramide cream for skin diseases with barrier dysfunction	—

Countries

Japan

Contacts

Public ContactKimiko Nakajima

Kochi Medical School, Kochi University Department of Dermatology

nakajimk@kochi-u.ac.jp088-866-5811

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026